Morning Overview on MSN

Experimental injection reverses osteoarthritis in animals within weeks

A single shot into a damaged joint reversed osteoarthritis in animals within weeks, according to researchers at the ...

Septerna, Inc.: Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism

Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers Data Anticipated in Late 2026 or Early 2027 SOUTH SAN FRANCISCO, Calif., Apr ...